Search results

Search market news

20 stories
invezz

Coca-Cola stock surges on strong earnings and FIFA sales boost

Coca-Cola raised its annual revenue and profit forecasts on Tuesday.The company reported stronger-than-expected second-quarter earnings.Demand for its Zero Sugar beverages, Fairlife milk and premium products remained strong.This came despite an uncertain consumer spending environment.Shares of the…

Invezz en_IN
StocksUS

REG - Victrex PLC Schroders PLC - Holding(s) in Company

RNS Number : 2126O Victrex PLC 28 July 2026  TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB0009292243Issuer NameVICTREX PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obl…

London Stock Exchange en_IN
StocksGB

Fed’s Kevin Warsh Faces Oil-Driven Inflation Test — Jeremy Siegel Sees 5%-10% Upside For Markets If Strait Of Hormuz Reopens

Federal Reserve Chair Kevin Warsh's upcoming press conference on Wednesday will be in focus this week, according to Jeremy Siegel, professor emeritus of finance at the University of Pennsylvania’s Wharton School of Business, who said the central bank's assessment of rising oil prices could shape in…

Stocktwits en_IN
Economy

REG - Societe Generale SA Rotork PLC - Form 8.3 - Rotork plc

RNS Number : 2125O Societe Generale SA 28 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING…

London Stock Exchange en_IN
StocksGB
tradingview

American Tower reports Q2 2026: revenue $2.749B, net income $888M, AFFO $1.264B

American Tower reported second-quarter 2026 results with total revenue of $2,749.1 million and net income of $887.5 million, reflecting strong year-over-year improvement. Adjusted EBITDA was $1,808.2 million and AFFO attributable to common stockholders was $1,264.1 million ($2.71 per diluted share…

TradingView en_IN
StocksUS
tradingview

Altimmune reports positive Phase 2 RECLAIM topline results for pemvidutide in AUD

Altimmune announced positive topline Phase 2 results for pemvidutide 2.4 mg showing a significant reduction in heavy drinking days versus placebo.Key Highlights:Original SEC Filing: Altimmune, Inc. [ ALT ] - 8-K - Jul. 28, 2026This is an AI-powered summary. It may contain inaccuracies. Consider ver…

TradingView en_IN
StocksUS
tradingview

Xylem reports Q2 2026: Revenue $2.34B, Net income $263M, Adjusted EPS $1.46

Xylem reported second-quarter 2026 results with revenue of $2.336 billion and net income attributable to Xylem of $263 million (diluted EPS $1.11). Adjusted diluted EPS for the quarter was $1.46 and adjusted EBITDA margin for Q2 was 23.3%. The company raised its full-year adjusted EPS guidance to…

TradingView en_IN
StocksUS